Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients With Advanced Cancer
The goal of this clinical trial is to test the efficacy a new psychosocial symptom management intervention called ENGAGE for patients with Stage IV breast, prostate, lung, or colorectal cancer. Participants will be randomized to ENGAGE or a Supportive Care intervention. Patient-reported outcomes will be assessed at baseline, 2 months, and 4 months.
• Receiving cancer care at a Duke Cancer Network (DCN) clinic
• Oncologist confirmed Stage IV breast, prostate, lung, or colorectal cancer
• Worst pain, fatigue, or distress rated at \>/= 3 out of 10 in the past 7 days for at least 2 symptoms
• MD Anderson Symptom Inventory (MDASI) Interference with Daily Living Scale average score of \>/= 3 out of 10 in the past 7 days
• Eastern Cooperative Oncology Group (ECOG) performance status of 2 or lower
• At least 18 years old
• Ability to speak and read English
• Hearing and vision that allows for successful completion of telehealth sessions